Today in News History
On July 12, several notable moments in the history of News stand out. In 1754, Thomas Bowdler, English physician and philanthropist (died 1825) was born. In 1927, Theodore Maiman, American-Canadian physicist and engineer (died 2007) was born. In 1959, Suzanne Vega, American singer-songwriter, guitarist, and producer was born. In 1968, Michael Geist, Canadian journalist and academic was born. In 1980, Kevin Powers, American soldier and author was born. In 1980, Tyson Kidd, Canadian wrestler was born. In 1994, Gary Kildall, American computer scientist, founded Digital Research (born 1942) passed away. In 2008, Michael E. DeBakey, American surgeon and educator (born 1908) passed away. In 2013, Emik Avakian, Iranian-American inventor (born 1923) passed away. In 2015, André Leysen, Belgian businessman (born 1927) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Bio-Techne expands AI-engineered protein portfolio for cell therapy
Narrative Intelligence Brief
This article was published by Investing.com, a source frequently categorized with a center bias based in Israel. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Investing.com, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from Investing.com
July 12, 2026
Ford, Canada’s Unifor reach tentative deal on labor contract
July 12, 2026
5 people shot, 2 dead in Toronto active shooter incident, police say
July 12, 2026
Typhoon Bavi batters east China, Taiwan reports 134 injured
July 12, 2026
Ford, Canada’s Unifor reach tentative deal on labor contract
July 12, 2026
Bangladesh’s first nuclear plant highlights emerging markets’ energy shift
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"jude bellingham"
Tuchel angry at 'lucky' and 'sloppy' England – can 'mentality' be enough?
Tuchel angry at 'lucky' and 'sloppy' England – can 'mentality' be enough?
2026 World Cup Golden Boot Odds: Jude Bellingham Skyrockets After Brace
How other outlets are covering this story
Compare narratives across 3 related reports from 3 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
3 sources
Left 33%
Center 33%
Right 0%
The Motley Fool
· Jul 11, 2026
5 Unstoppable Semiconductor Stocks You Can Buy Now in July (2026)
The proliferation of agentic AI is fueling the next leg of growth for semiconductor stocks.
https://cdn.mos.cms.futurecdn.net/atntNFPM5sSSnaYvgwZoQ6.jpg
· Jul 9, 2026
Micron Gives Stocks a $250 Billion AI Boost: Stock Market Today
Micron Gives Stocks a $250 Billion AI Boost: Stock Market Today
Financial Times
· Jun 30, 2026
Anthropic launches Claude Science in push for pharma revenue
New AI product has use cases in rendering 3D protein structures and drug discovery
Topics:
Related coverage for "Bio-Techne expands AI-engineered protein portfolio for cell therapy": The Motley Fool — 5 Unstoppable Semiconductor Stocks You Can Buy Now in July (2026). https://cdn.mos.cms.futurecdn.net/atntNFPM5sSSnaYvgwZoQ6.jpg — Micron Gives Stocks a $250 Billion AI Boost: Stock Market Today . Financial Times — Anthropic launches Claude Science in push for pharma revenue